198 related articles for article (PubMed ID: 1933580)
1. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
Evans RA; Somers NM; Dunstan CR; Hills E; Evans M
Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
Muff R; Dambacher MA; Perrenoud A; Simon C; Fischer JA
Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666
[TBL] [Abstract][Full Text] [Related]
3. Long-term experience with a calcium-thiazide treatment for Paget's disease of bone.
Evans RA; Dunstan CR; Wong SY; Hills E
Miner Electrolyte Metab; 1982 Dec; 8(6):325-33. PubMed ID: 7167138
[TBL] [Abstract][Full Text] [Related]
4. [Calcitonin nasal spray for Paget's disease of the bone].
Luboshitzky R; Bar-Shalom R
Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
[TBL] [Abstract][Full Text] [Related]
5. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
O'Donoghue DJ; Hosking DJ
Bone; 1987; 8(4):219-25. PubMed ID: 3128315
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease.
González D; Vega E; Ghiringhelli G; Mautalen C
Calcif Tissue Int; 1987 Dec; 41(6):313-5. PubMed ID: 3124939
[TBL] [Abstract][Full Text] [Related]
7. [Salmon calcitonin nasal spray in the treatment of Paget's disease].
Giustina A; Macca C; Bossoni S; Romanelli G; Zuccato F
Recenti Prog Med; 1989 Nov; 80(11):599-602. PubMed ID: 2623325
[TBL] [Abstract][Full Text] [Related]
8. Intranasal salmon calcitonin treatment of Paget's disease of bone. Results in nine patients.
D'Agostino HR; Barnett CA; Zielinski XJ; Gordan GS
Clin Orthop Relat Res; 1988 May; (230):223-8. PubMed ID: 3365896
[TBL] [Abstract][Full Text] [Related]
9. Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.
Reginster JY; Albert A; Franchimont P
Calcif Tissue Int; 1985 Dec; 37(6):577-80. PubMed ID: 3937575
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Paget's disease of bone with salmon calcitonin nasal spray.
Gagel RF; Logan C; Mallette LE
J Am Geriatr Soc; 1988 Nov; 36(11):1010-4. PubMed ID: 3171038
[TBL] [Abstract][Full Text] [Related]
11. One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray.
Reginster JY; Jeugmans-Huynen AM; Albert A; Denis D; Franchimont P
J Bone Miner Res; 1988 Jun; 3(3):249-52. PubMed ID: 3213619
[TBL] [Abstract][Full Text] [Related]
12. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
Chapuy MC; Meunier P; Terrier M; David L; Vignon G
Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
[TBL] [Abstract][Full Text] [Related]
13. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
Avramides A; Flores A; DeRose J; Wallach S
J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
[TBL] [Abstract][Full Text] [Related]
14. Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
Reginster JY; Gennari C; Mautalen C; Deroisy R; Denis D; Lecart MP; Vandalem JL; Collette J; Franchimont P
Scand J Rheumatol; 1990; 19(1):83-6. PubMed ID: 2309107
[No Abstract] [Full Text] [Related]
15. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of Paget's disease of bone with salmon calcitonin.
Sturtridge WC; Harrison JE; Wilson DR
Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
[TBL] [Abstract][Full Text] [Related]
17. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease.
Levy F; Muff R; Dotti-Sigrist S; Dambacher MA; Fischer JA
J Clin Endocrinol Metab; 1988 Sep; 67(3):541-5. PubMed ID: 3410939
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
Avramides A; Baker RK; Wallach S
Metabolism; 1974 Nov; 23(11):1037-46. PubMed ID: 4472557
[No Abstract] [Full Text] [Related]
19. Treatment of Paget's disease of bone.
Evans RA
Med J Aust; 1983 Feb; 1(4):159-62. PubMed ID: 6405139
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
Delmas PD; Chapuy MC; Meunier PJ
Horm Metab Res; 1984 May; 16(5):258-61. PubMed ID: 6234216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
